Ginkgo Biloba (Blackmores)
What to know about Ginkgo Biloba — also sold as Blackmores, Swisse: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
Ginkgo Biloba (brand names: Blackmores, Swisse) is classified as Low risk (1 risk points) by AllMeds. CAUTION: antiplatelet effect. Increases bleeding risk with warfarin, NSAIDs, aspirin.
Key Takeaways
- Risk level: Low (1 points)
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | Unscheduled | Not PBS listed |
Risk Profile
CAUTION: antiplatelet effect. Increases bleeding risk with warfarin, NSAIDs, aspirin.
How Ginkgo Biloba is regulated
Ginkgo Biloba is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Australia TGA / PBS / State Schemes
Classified as Unscheduled under the Therapeutic Goods Administration (TGA).
Clinical Evidence
- Ginkgo biloba — Cochrane review for cognitive impairment (2009)
Cochrane review finding inconsistent evidence for cognitive benefit. KEY: antiplatelet effect increases bleeding risk with warfarin, NSAIDs, aspirin.
Cochrane review — interaction profile more important than efficacy for AllMeds
Check this medication against your full medication list
Run a full risk assessment including Ginkgo Biloba interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.